Introduction: Diabetes is associated with the development of many cardiovascular diseases (CVD). Diabetes impairs the utilization of lipids and lipoproteins which cause diabetes induced atherogenic dyslipidemia that, is one of the most important risk factor for the development of atherosclerosis in diabetic individuals. Objectives: The basic aim of the study was to analyse the lipid profile in diabetic and non-diabetic patients with ischemic heart disease. Material and methods: This cross sectional study was conducted in Holy Family Hospital, Rawalpindi during June 2019 to December 2019. The data was collected from 100 patients of both genders. The data were collected through randomly selected sampling technique. There were two groups of st...
Introduction: The reduction of cardiovascular risk by lowering low-density lipoprotein cholesterol (...
Introduction: The reduction of cardiovascular risk by lowering low-density lipoprotein cholesterol (...
Aim: To determine the pattern of dyslipidemia and the extent to which lipid therapy may reduce the r...
Introduction: Diabetes is associated with the development of many cardiovascular diseases (CVD). Dia...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Objective: To compare the mean lipid profile between type-II diabetics and non-diabetics at tertiar...
OBJECTIVE: To compare the lipid profile in diabetic (type 2) with non-diabetic’s population. PATIE...
Aims and objectives: Diabetes is associated with the development of many cardiovascular diseases (CV...
Background: Diabetes mellitus (T2DM) is the most common metabolic disorder in human beings. It is a ...
Diabetes mellitus causes lipid profile abnormalities, resulting in dyslipidemia in diabetic patients...
Objective: To compare transmission, control of disease and some other aspects between the patients o...
Introduction: Diabetic dyslipidemia is regarded as risk factor for development of cardiovascular dis...
Introduction: The reduction of cardiovascular risk by lowering low-density lipoprotein cholesterol (...
Introduction: The reduction of cardiovascular risk by lowering low-density lipoprotein cholesterol (...
Aim: To determine the pattern of dyslipidemia and the extent to which lipid therapy may reduce the r...
Introduction: Diabetes is associated with the development of many cardiovascular diseases (CVD). Dia...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Introduction: Cardio Vascular Disease (CVD) is a leading cause of death in the world. In Sri Lanka 4...
Objective: To compare the mean lipid profile between type-II diabetics and non-diabetics at tertiar...
OBJECTIVE: To compare the lipid profile in diabetic (type 2) with non-diabetic’s population. PATIE...
Aims and objectives: Diabetes is associated with the development of many cardiovascular diseases (CV...
Background: Diabetes mellitus (T2DM) is the most common metabolic disorder in human beings. It is a ...
Diabetes mellitus causes lipid profile abnormalities, resulting in dyslipidemia in diabetic patients...
Objective: To compare transmission, control of disease and some other aspects between the patients o...
Introduction: Diabetic dyslipidemia is regarded as risk factor for development of cardiovascular dis...
Introduction: The reduction of cardiovascular risk by lowering low-density lipoprotein cholesterol (...
Introduction: The reduction of cardiovascular risk by lowering low-density lipoprotein cholesterol (...
Aim: To determine the pattern of dyslipidemia and the extent to which lipid therapy may reduce the r...